KALA BIO
KALA
83 hedge funds and large institutions have $353M invested in KALA BIO in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 13 closing their positions.
338% more capital invested
Capital invested by funds: $80.7M → $353M (+$273M)
169% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 13
83% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 12
32% more funds holding
Funds holding: 63 → 83 (+20)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
56% less call options, than puts
Call options by funds: $6.5M | Put options by funds: $14.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$40.5M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$18.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.2M |
| 4 |
O
OrbiMed
New York
|
+$12.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$3.42M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$3.39M |
| 3 |
First Manhattan
New York
|
-$3.04M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.14M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$687K | -43 | Closed |
|
|
AG
102
Algert Global
San Francisco,
California
| – | -$174K | -19 | Closed |
|
|
HF
103
HRT Financial
New York
| – | -$60K | -7 | Closed |
|
104
Group One Trading
Chicago,
Illinois
| – | -$79.9K | -5 | Closed |
|
|
TRCT
105
Tower Research Capital (TRC)
New York
| – | -$45K | -5 | Closed |
|
|
AIM
106
Alambic Investment Management
Belvedere,
California
| – | -$40K | -4 | Closed |
|
107
Squarepoint
New York
| – | -$41K | -4 | Closed |
|
|
PHK
108
Point72 Hong Kong
Hong Kong
| – | -$5K | -1 | Closed |
|
KALA Hedge Fund Activity: Q1 2020 in Review
83 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2020, worth a combined $353M — up 338% from $80.7M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new KALA positions and 13 closed out — a net gain of 22 holders — while 22 added to existing stakes and 12 trimmed.
The largest buyer was RA Capital Management, adding an estimated $40.5M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $3.42M sold.
- 83 institutional investors held KALA BIO (KALA) as of Q1 2020, up from 63 in Q4 2019.
- Funds reported $353M of KALA BIO stock for Q1 2020, up 338% quarter-over-quarter.
- 35 funds opened new KALA BIO positions in Q1 2020 and 13 closed out, a net change of +22 holders.
- The largest KALA BIO buyer in Q1 2020 was RA Capital Management, an estimated $40.5M added.
- The largest KALA BIO seller in Q1 2020 was Pura Vida Investments, an estimated $3.42M sold.
Based on aggregated 13F filings for Q1 2020.